Related Experiment Video

Updated: Oct 16, 2025

Standardized Rat Coronary Ring Preparation and Real-Time Recording of Dynamic Tension Changes Along Vessel Diameter
07:53

Standardized Rat Coronary Ring Preparation and Real-Time Recording of Dynamic Tension Changes Along Vessel Diameter

Published on: June 16, 2022

3.4K

Pharmacologic Management of Coronary Artery Ectasia

Anwar Khedr1, Bandana Neupane2, Ekaterina Proskuriakova1

  • 1Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.

Cureus
|October 18, 2021
PubMed

Insights

Coronary artery ectasia (CAE) management focuses on preventing complications like angina and acute coronary syndrome. Key treatments include antiplatelets, statins for atherosclerosis, and individualized anticoagulation, while nitrates are generally avoided.

Area of Science:

  • Cardiology
  • Vascular Medicine

Background:

  • Coronary artery ectasia (CAE) is a rare aneurysmal condition of the coronary arteries.
  • CAE involves significant arterial dilatation, increasing risks of angina pectoris and acute coronary syndrome.

Purpose of the Study:

  • To review pharmacologic strategies for primary and secondary prevention of CAE complications.
  • To outline evidence-based treatment options for managing patients with coronary artery ectasia.

Main Methods:

  • Literature review of pharmacologic interventions for CAE.
  • Analysis of treatment guidelines and clinical evidence for CAE management.

Main Results:

  • Antiplatelets (e.g., aspirin) are foundational treatments.
  • Statins are indicated for all patients due to atherosclerosis being a common cause.
  • Anticoagulants are used selectively; ACE inhibitors, beta-blockers, and calcium channel blockers have specific indications.
  • Nitrates are generally contraindicated, while trimetazidine may improve exercise tolerance.

Conclusions:

  • Pharmacologic management of CAE requires a multi-faceted approach tailored to individual patient risk factors.
  • Effective prevention of CAE complications involves a combination of antiplatelet therapy, statins, and other targeted medications based on clinical presentation.

Keywords:
ace inhibitorsaneurysmal coronary artery diseaseaspirinb-blockersca channel blockerscoronary artery ectasia (cae)nitratesstatinstrimetazidinewarfarin therapy

More Related Videos

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration07:59

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

Published on: April 4, 2022

1.4K
Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

3.8K

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
68
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
48
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
70
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
63
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
56
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
772